Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5433_Библиотеки_им_академика_М_И_Перельмана
.pdf
Chemical and Clinical
Applications of Tempol
A comprehensive and authoritative exploration of Tempol (4‑Hydroxy‑
TEMPO), an exceptional chemical compound with diverse applications in
both scientic research and medical practice. This book delves into Tempol’s
unique properties, mechanisms of action, and its potential role in combating
oxidative stress‑related disorders. It includes a chapter devoted to the safe
handling, storage, and disposal of Tempol in compliance with pharmaceutical
regulations. The authors pay particular attention to pharmaceutical regula‑
tions in the industry.
Chemical and Clinical
Applications of Tempol
A Marvelous Molecule
Abhishek Tiwari, Varsha Tiwari and
Bimal K. Banik
First edition published 2025
by Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300, Boca Raton, Florida 33487, U.S.A.
and by CRC Press
4 Park Square, Milton Park, Abingdon, Oxon, OX14 4RN
CRC Press is an imprint of Taylor & Francis Group, LLC
© 2025 Taylor & Francis Group, LLC
Reasonable eorts have been made to publish reliable data and information, but the
author and publisher cannot assume responsibility for the validity of all materials or
the consequences of their use. e authors and publishers have attempted to trace
the copyright holders of all material reproduced in this publication and apologize to
copyright holders if permission to publish in this form has not been obtained. If any
copyright material has not been acknowledged please write and let us know so we
may rectify in any future reprint.
Except as permit ted under U.S. Copy right Law, no part of th is book may be reprinted,
reproduced, transmitted, or utilized in any form by any electronic, mechanical, or
other means, now known or hereaf ter invented, including photocopying, microlm‑
ing, and recording, or in any information storage or retrieval system, without writ‑
ten permission from the publishers.
For permission to photocopy or use material electronically from this work, access
www.copyright.com or contact the Copyright Clearance Center, Inc. (CCC), 222
Rosewood Drive, Danvers, MA 01923, 978‑750‑8400. For works that are not avail‑
able on CCC please contact mpkbookspermissions@tandf.co.uk
Trademark notice: Product or corporate names may be trademarks or registered
trademarks and are used only for identication and explanation without intent to
infringe.
ISBN: 9781032730028 (hbk)
ISBN: 9781032731223 (pbk)
ISBN: 9781003426820 (ebk)
DOI: 10.1201/9781003426820
Typeset in Times
by codeMantra
v
Contents
Preface vii
Author biographies ix
Acknowledgments xiii
1 Introduction to Tempol 1
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
2 Synthesis and chemical reactions of Tempol 18
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
3 Tempol in the synthesis of Terpenoids 33
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
4 Name reactions involved in TEMPOL 43
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
5 Industrial applications of TEMPOL 53
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
6 The Role of Tempol in NRTI-Induced Mitochondrial toxicity 65
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
7 The signicance of Tempol in diabetic nephropathy 75
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
https://t.me/med1917
vi Contents
8 Mechanistic insights into the reaction between a
nitroxide radical (Tempol) and a phenolic antioxidant 86
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
9 Tempol: an ocular neuroprotectant 97
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
10 Miracle drug Tempol in cancer treatment 111
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
11 Tempol as reactive oxygen inhibitor 127
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
12 Nano-formulations of Tempol 149
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
13 Safe handling, storage, and disposal of 4-Hydroxy-
TEMPO in compliance with pharmaceutical regulations 163
Abhishek Tiwari, Varsha Tiwari,
and Bimal Krishna Banik
https://t.me/med1917
vii
Preface
In the dynamic world of chemical and clinical research, certain molecules
stand out for their remarkable versatility and potential. One such molecule
is Tempol, also known as 4‑Hydroxy‑TEMPO, which has garnered signi‑
cant attention due to its wide‑ranging applications across various scientic
and industrial domains. This book, Chemical and Clinical Applications of
Tempol: A Marvelous Molecule, aims to provide a comprehensive overview
of the multifaceted roles of Tempol, from its fundamental properties and syn‑
thesis to its impactful applications in medicine and industry.
Chapter 1, “A Brief Account on Tempol,” introduces the molecule,
exploring its history, structure, and the initial discoveries that highlighted its
potential. This chapter sets the stage for a deeper understanding of Tempol’s
signicance in the scientic community.
In Chapter 2, “Synthesis and Chemical Reactions of Tempol,” we delve
into the methodologies employed to synthesize Tempol and the various chem‑
ical reactions it undergoes. This chapter provides essential knowledge for
researchers interested in the practical aspects of working with this molecule.
Chapter 3, “Tempol in the Synthesis of Terpenoids,” illustrates how
Tempol serves as a valuable reagent in the synthesis of terpenoids, a class
of organic compounds with numerous applications in pharmaceuticals and
biotechnology.
The exploration continues in Chapter 4, “Name Reactions Involved in
Tempol,” where we discuss prominently named reactions that utilize Tempol,
emphasizing its role in facilitating key chemical transformations.
In Chapter 5, “Industrial Applications of Tempol,” we shift our focus to
the commercial realm, detailing how Tempol is employed in various indus‑
tries, including its uses in manufacturing processes and product development.
Chapter 6, “The Role of Tempol in NRTI‑Induced Mitochondrial
Toxicity,” examines the clinical implications of Tempol, particularly its abil‑
ity to mitigate mitochondrial toxicity induced by nucleoside reverse tran‑
scriptase inhibitors (NRTIs), which are crucial in HIV treatment regimens.
The therapeutic potential of Tempol is further explored in Chapter 7,
“The Signicance of Tempol in Diabetic Nephropathy,” where we highlight
its protective effects against diabetic kidney disease, a major complication of
diabetes.
https://t.me/med1917
viii Preface
In Chapter 8, “Mechan istic Insights into the Reaction Between a Nitroxide
Radical (Tempol) and a Phenolic Antioxidant,” we provide a detailed analysis
of the interactions between Tempol and phenolic antioxidants, shedding light
on the underlying mechanisms that drive these reactions.
Chapter 9, “Tempol: An Ocular Neuroprotectant,” focuses on the neuro‑
protective properties of Tempol, particularly in the context of ocular health,
offering insights into its potential to prevent or treat neurodegenerative condi‑
tions affecting the eye.
The promising role of Tempol in oncology is discussed in Chapter 10,
“Miracle Drug Tempol in Cancer Treatment.” This chapter explores the
emerging evidence supporting Tempol’s effectiveness as an adjunct in cancer
therapy, highlighting its potential to enhance treatment outcomes.
Chapter 11, “Tempol as a Reactive Oxygen Inhibitor,” delves into the
molecule’s ability to inhibit reactive oxygen species, positioning Tempol as a
critical agent in combating oxidative stress‑related conditions.
The innovative realm of nanotechnology is covered in Chapter 12,
“Nano‑Formulations of Tempol,” where we discuss the development and
advantages of nano‑formulations, providing a forward‑looking perspective
on Tempol’s application in advanced drug delivery systems.
Finally, Chapter 13, “Safe Handling, Storage, and Disposal of
4‑Hydroxy‑TEMPO in Compliance with Pharmaceutical Regulations,”
addresses the practical aspects of working with Tempol, ensuring that
researchers and industry professionals adhere to best practices and regula‑
tory requirements to maintain safety and efcacy.
This book aims to serve as an invaluable resource for chemists, clini‑
cians, and industry professionals alike, offering a thorough understanding
of Tempol’s chemical properties, applications, and therapeutic potential. We
hope that the insights and knowledge shared within these pages will inspire
further research and innovation, harnessing the full potential of this marvel‑
ous molecule.
https://t.me/med1917
ix
Author biographies
Dr. Abhishek Tiwari is working as Professor
and Head in the Department of Pharmaceutical
Chemistry, Amity Institute of Pharmacy. Amity
University Lucknow Campus, Lucknow, India. He
obtained his BPharm degree from Jiwaji University
Gwalior (MP), MPharm from MS Ramaiah College
of Pharmacy, Bengaluru (Karnataka), and PhD
from Uttarakhand Technical University, Dehradun
(Uttarakhand). He has received grants of more
than Rs. 8.5 million from the Department of
Biotechnology, Uttarakhand; All India Council of
Technical Education, India; CCRUM, India; and Power Finance Corporation.
He has been granted 25granted patents and 11 design patents. In addition,
he has submitted a number of patents for approval. He is an editorial mem‑
ber of various national and international journals. He received “Outstanding
Academic and Research Award” in 2021, “Best Author Award” in 2019,
“Best Teacher Award” in 2019, and “Outstanding Teacher Award” in 2014
and 2015. He has published 78 papers in international journals. He is a rec‑
ognized PhD supervisor of Uttarakhand Technical University, Dehradun and
Amity University, Lucknow Campus. He has mentored around 80 students in
research, including 2 PhD research scientists.
Dr.Varsha Tiwari
is working as Professor in the
Department of Pharmacognosy, Amity Institute
of Pharmacy. Amity University Lucknow
Campus, Lucknow, India. She obtained her
BPharm degree from Jiwaji University Gwalior
(MP), MPharm. from MS Ramaiah College
of Pharmacy, Bengaluru (Karnataka), and
PhD from Uttarakhand Technical University,
Dehradun (Uttarakhand). She has been granted
24 patents and 11 design patents. In addi‑
tion, she has submitted a number of patents for approval. She has received
“Young scientist Award” in 2022, “Young Teacher Award” in 2020, “Pharma
https://t.me/med1917
x Author biographies
Recognition Award” in 2019, and “Outstanding Teacher Award” in 2015.
She has published 68 research papers in national and international journals.
Remarkably, she has published more than 15 books and 20 chapters. She is
a recognized PhD supervisor of Amity University, Lucknow Campus, India.
She has delivered several lectures as an eminent speaker in National and
International Conferences. Her core area includes diabetes, nanotechnol‑
ogy, phytochemistry, and chromatography‑based analysis. She has mentored
around 88 students in research, including 1 PhD research scientists.
Prof. Bimal Krishna Banik
conducted his
doctoral research at the Indian Association for
the Cultivation of Science, Calcutta. Then, he
pursued postdoctoral research at Case Western
Reserve University and Stevens Institute of
Technology. He was a Tenured Full Professor
of Chemistry and First President’s Endowed
Professor of Science & Engineering at the
University of Texas‑Pan American. He was also
the Vice President of Research & Education
Development of the Community Health Systems
of Texas. At present, he is a full professor of the Deanship of Research
Development at the Prince Mohammad Bin Fahd University (Kingdom of
Saudi Arabia).
Professor Banik taught chemistry to BS, MS, and PhD students in the United
States and Saudi Arabia universities for many years. In research, he directly
mentored approximately 300 students, 20 postdoctoral fellows, 7 PhD
research scientists, and 28 university/college faculties. He acted as the advi‑
sor of two students’ organizations that had1,400 students. As the principal
investigator (PI), he was awarded $7.25million in grants from NIH and NCI.
Importantly, he has about 680 publications along with more than 500 presen‑
tation abstracts. Many of his international presentations were designated as
Keynote and Plenary lectures.
Professor Banik served as the PI of a joint green chemistry symposium
between the United States and India. He chaired 20 symposiums at the
American Chemical Society (ACS) National Meetings and over two dozen at
the International level, including one at the Nobel Prize Celebration. In the
capacity of chair, he introduced about 300 speakers. He is a reviewer of 93,
editorial board member of 26, editor‑in‑chief of 12, founder of 8, and guest
editor of 10 research journals. As the editor‑in‑chief, he recruited approxi‑
mately 200 associate editors and editorial board members. He is an examiner
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана